The 4 points where rare disease launches break down
In rare disease launches, every specialist interaction matters. Yet many organizations unintentionally create friction through misaligned priorities,…
Why pharma brand launches fail and how to improve success
Why do so many pharmaceutical brand launches miss their targets? Our one-pager dives into the key reasons behind launch failures and offers actionable recommendations to overcome them. Learn how to address common pitfalls and improve your chances of long-term success in the competitive pharmaceutical market.
Explore other resources
All
- All
- One-Pager
- White Paper
The right-sized launch
When launch budgets shrink, training priorities become even more important. This one-pager outlines a practical framework for…
Are your medical and sales teams actually ready to launch together?
Most pharma launches fail not because the science is wrong, but because the people delivering it are…
The Cross‑Functional Collaboration Framework for Rare Disease Launches
Rare disease launches place extraordinary demands on the field. Medical, commercial, and market access teams are often…
Stay ahead of the game with regular updates
